Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Operating Leases (2019 - 2025)

STRATA Skin Sciences (SSKN) has disclosed Operating Leases for 7 consecutive years, with $688000.0 as the latest value for Q4 2025.

  • Quarterly Operating Leases fell 25.14% to $688000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $688000.0 through Dec 2025, down 25.14% year-over-year, with the annual reading at $688000.0 for FY2025, 25.14% down from the prior year.
  • Operating Leases hit $688000.0 in Q4 2025 for STRATA Skin Sciences, down from $736000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $1.2 million in Q1 2024 to a low of $237000.0 in Q4 2023.
  • Historically, Operating Leases has averaged $638350.0 across 5 years, with a median of $611500.0 in 2021.
  • Biggest five-year swings in Operating Leases: plummeted 61.15% in 2023 and later soared 287.76% in 2024.
  • Year by year, Operating Leases stood at $392000.0 in 2021, then skyrocketed by 55.61% to $610000.0 in 2022, then tumbled by 61.15% to $237000.0 in 2023, then skyrocketed by 287.76% to $919000.0 in 2024, then decreased by 25.14% to $688000.0 in 2025.
  • Business Quant data shows Operating Leases for SSKN at $688000.0 in Q4 2025, $736000.0 in Q3 2025, and $1.1 million in Q2 2025.